Rock Health, the San Francisco-based seed fund focused on digital health startups, announced Monday it had invested in a half-dozen additional startups, including Accountable, Acumen, Aptible, Benchling, Telepharm and Welkin Health. It put money into three more companies still in stealth mode. Deal terms weren’t disclosed. The firm also brought aboard three new corporate partners, which provide advice and support (but not funding) for Rock Health’s portfolio companies, including: Abbott, Blue Shield of California and Deloitte’s life sciences and health care practice.
This article originally appeared on Recode.net.
